Seven patients with SMA had myostatin levels at the detection threshold of the method, with four out of the seven being patients with SMA type 1 aged between 3 and 8 years, all in advanced stages, and one out of the seven being a patient with SMA type 3 with a disease duration of 38 years. The gene discussed is MSTN; the disease is spinal muscular atrophy, type 1.